Today’s media landscape is constantly evolving toward more efficient tools of communication that can gather unprecedented amounts of information. This new media landscape offers tremendous opportunity for the public, health care professionals, pharmaceutical companies, biomedical researchers, and public health agencies to share, discuss, inquire, and report health care information using traditional and innovative media tools. The new social media landscape also encourages health care professionals and pharmaceutical companies to face the dilemma of engaging consumers without the fear of liability when clarifying, monitoring and reporting the adverse events. This dilemma creates an important role for the government to step in and engage all the stakeholders of public health and proactively monitor and regulate the adverse events. The public databases hosted by the federal government serve as important information hubs to collect, evaluate and distribute health care information, which plays important role in diseases control and prevention in the changing media landscape and new information ecology.
Citation: Feng X, Cai A, Dong K, Chaing W, Feng M, et al. (2013) Assessing Pancreatic Cancer Risk Associated with Dipeptidyl Peptidase 4 Inhibitors: Data Mining of FDA Adverse Event Reporting System (FAERS). J Pharmacovigilance 1:110.